October 2008, Vol 1, No 8

October 2008, Vol 1, No 8

Writing Research Articles on Benefit Design and Policy

William E. Fassett, BSPharm, MBA, PhD, Charles R. Phillips, PharmD, PhD

October 2008, Vol 1, No 8 - Editorial

Cutting Through the Politics: Presidential Candidates? Healthcare Platforms and Impact on Health Benefits

Peyton Howell, MHA

October 2008, Vol 1, No 8 - Regulatory

Stakeholder Perspective

Health Reform and the Next President

by Joseph R. Antos, PhD

Medication Therapy Management Goes Hi-Tech: Implementing Automated Software Improves Pharmacy Efficiency

Adrienne Giordano, PharmD, Carrie Holden, PharmD, Cathrine Misquitta, PharmD, BCPS

October 2008, Vol 1, No 8 - Business

Stakeholder Perspective

Automated MTM Programs

by Scott R. Taylor, RPh, MBA

Presidential Candidates Strong Supporters of Greater Access to Generics and Biosimilars

Dalia Buffery, MA, ABD

October 2008, Vol 1, No 8 - Industry Trends

Cost-Effectiveness of Second-Generation Antihistamines and Montelukast in Relieving Allergic Rhinitis Nasal Symptoms

Michael J. Goodman, PhD, Mehul Jhaveri, PharmD, Kim Saverno, PhD, Kellie Meyer, PharmD, Brian Nightengale, PhD

October 2008, Vol 1, No 8 - Business

Stakeholder Perspective

Relieving Nasal Symptoms: Uncommon Excellence in a Common Clinical Condition

by Michael F. Murphy, MD, PhD

New Reporting System for Potential Safety Concerns of Drugs on the Market

October 2008, Vol 1, No 8 - FDA Approvals

Evaluation and Management of Diabetes Mellitus

Loida Nguyen, PharmD, James V. Felicetta, MD, Quang T. Nguyen, DO, FACE, FTOS

October 2008, Vol 1, No 8 - Clinical

Stakeholder Perspective

Evidence-Based Diabetes Management

by Thomas McCarter, MD, FACP

Results 1 - 7 of 7